Dashboard
Manage Tickers

NKTR


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nektar-therapeutics-enters-equity-distribution-agreement-with-piper-sandler--btig-may-sell-shares-worth-up-to-110m
Nektar Therapeutics Enters Equity Distribu...
11/12/2025 22:31:02

- SEC Filing

nektar-therapeutics-files-for-mixed-shelf-offering-size-not-disclosed
Nektar Therapeutics Files For Mixed Shelf ...
11/12/2025 21:46:30

- SEC Filing

reported-saturday-nektar-therapeutics-presents-late-breaking-rezolve-ad-data-showing-clinically-meaningful-easi-75-and-easi-90-improvements-at-acaai-2025
Reported Saturday, Nektar Therapeutics Pre...
11/10/2025 08:46:17

Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo i...

nektar-therapeutics-q3-eps-187-beats-269-estimate-sales-11790m-beat-10048m-estimate
Nektar Therapeutics Q3 EPS $(1.87) Beats $...
11/06/2025 21:21:49

Nektar Therapeutics (NASDAQ:NKTR) reported quarterly losses of $(1.87) per share which beat the analyst consensus estimate of $...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

nektar-therapeutics-announced-data-from-rezolve-ad-phase-2b-study-for-rezpegaldesleukin-accepted-for-late-breaking-oral-abstract-presentation-at-acaai-2025-annual-scientific-meeting
Nektar Therapeutics Announced Data From RE...
10/22/2025 12:06:17

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/03/2025 17:35:44

b-riley-securities-maintains-buy-on-nektar-therapeutics-raises-price-target-to-105
B. Riley Securities Maintains Buy on Nekta...
09/23/2025 18:09:04

B. Riley Securities analyst Mayank Mamtani maintains Nektar Therapeutics (NASDAQ:NKTR) with a Buy and raises the price targe...

btig-reiterates-buy-on-nektar-therapeutics-maintains-100-price-target
BTIG Reiterates Buy on Nektar Therapeutics...
09/19/2025 08:22:17

BTIG analyst Julian Harrison reiterates Nektar Therapeutics (NASDAQ:NKTR) with a Buy and maintains $100 price target.

nektar-therapeutics-announces-new-data-from-ongoing-rezolve-ad-phase-2b-study-of-rezpegaldesleukin-at-2025-eadv-congress
Nektar Therapeutics Announces New Data Fro...
09/18/2025 12:47:39

Study met primary and key secondary endpoints at week 16 in patients with moderate-to-severe atopic dermatitisHigh dose rezpega...

nektar-to-present-rezolve-ad-phase-2b-results-for-rezpegaldesleukin-in-atopic-dermatitis-at-eadv-2025-late-breaker-oral-session-on-sept-18-in-paris
Nektar To Present REZOLVE-AD Phase 2b Resu...
09/09/2025 11:04:23

whats-going-on-with-nektar-therapeutics-stock-on-thursday
What's Going On With Nektar Therapeutics S...
09/04/2025 18:52:30

Nektar Therapeutics stock is trading higher with no news, possibly due to Sanofi's disappointing results.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 17:05:59

shoe-carnival-american-eagle-ciena-victorias-secret-and-other-big-stocks-moving-higher-on-thursday
Shoe Carnival, American Eagle, Ciena, Vict...
09/04/2025 16:56:56

nektar-therapeutics-q2-eps-295-misses-292-estimate-sales-1118m-beat-1084m-estimate
Nektar Therapeutics Q2 EPS $(2.95) Misses ...
08/07/2025 20:16:56

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

fda-grants-nektar-therapeutics-fast-track-designation-for-rezpegaldesleukin-for-treatment-of-severe-to-very-severe-alopecia-areata
FDA Grants Nektar Therapeutics Fast Track ...
07/29/2025 13:06:32

b-riley-securities-maintains-buy-on-nektar-therapeutics-raises-price-target-to-85
B. Riley Securities Maintains Buy on Nekta...
07/08/2025 17:58:44

B. Riley Securities analyst Mayank Mamtani maintains Nektar Therapeutics (NASDAQ:NKTR) with a Buy and raises the price targe...

nektar-therapeutics-prices-underwritten-public-offering-of-100m-of-shares-at-2350shr
Nektar Therapeutics Prices Underwritten Pu...
07/01/2025 11:19:20

Nektar Therapeutics (NASDAQ:NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in...

us-stock-futures-slip-after-two-days-of-record-advances-fomo-could-add-another-5-10-says-expert
US Stock Futures Slip After Two Days Of Re...
07/01/2025 10:14:51

U.S. futures slipped on Tuesday after two days of record-setting advances. Futures of major benchmark indices were trading lower.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION